Vg Life Financials
| VGLS Stock | USD 0.0001 0.00 0.00% |
VGLS |
Please note, the imprecision that can be found in Vg Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vg Life Sciences. Check Vg Life's Beneish M Score to see the likelihood of Vg Life's management manipulating its earnings.
Vg Life Stock Summary
Vg Life competes with Sino Biopharmaceutica, Dominari Holdings, Pharming Group, and Silo Pharma. VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US91822T1016 |
| Business Address | 121 Gray Avenue, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.vglifesciences.com |
| Phone | 805 879 9000 |
| Currency | USD - US Dollar |
Vg Life Key Financial Ratios
There are many critical financial ratios that Vg Life's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vg Life Sciences reports annually and quarterly.| Return On Asset | -1.51 | |||
| Target Price | 0.15 | |||
| Beta | 2.76 |
VGLS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vg Life's current stock value. Our valuation model uses many indicators to compare Vg Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vg Life competition to find correlations between indicators driving Vg Life's intrinsic value. More Info.Vg Life Sciences is rated below average in return on asset category among its peers. It is rated first in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vg Life's earnings, one of the primary drivers of an investment's value.Vg Life Sciences Systematic Risk
Vg Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vg Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Vg Life Sciences correlated with the market. If Beta is less than 0 Vg Life generally moves in the opposite direction as compared to the market. If Vg Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vg Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vg Life is generally in the same direction as the market. If Beta > 1 Vg Life moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.